Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
52 hedge funds and large institutions have $279M invested in Gritstone bio, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 16 closing their positions.
69% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 16
44% more capital invested
Capital invested by funds: $194M → $279M (+$85.5M)
21% more funds holding
Funds holding: 43 → 52 (+9)
15.72% more ownership
Funds ownership: 46.74% → 62.46% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
+$49M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.9M |
| 3 |
BlackRock
New York
|
+$7.63M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.87M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$4.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$4.21M |
| 2 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$2.49M |
| 3 |
PC
PointState Capital
New York
|
-$1.85M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.61M |
| 5 |
Millennium Management
New York
|
-$1.23M |
GRTS Hedge Fund Activity: Q4 2018 in Review
52 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2018, worth a combined $279M — up 44% from $194M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new GRTS positions and 16 closed out — a net gain of 11 holders — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Blackstone Inc, opening a new position worth an estimated $49M. The largest seller was Goldman Sachs, exiting entirely with an estimated $4.21M sold.
- 52 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2018, up from 43 in Q3 2018.
- Funds reported $279M of Gritstone bio, Inc. Common Stock stock for Q4 2018, up 44% quarter-over-quarter.
- 27 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2018 and 16 closed out, a net change of +11 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q4 2018 was Blackstone Inc, an estimated $49M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q4 2018 was Goldman Sachs, an estimated $4.21M sold.
Based on aggregated 13F filings for Q4 2018.